eMedicine Specialties > Physical Medicine and Rehabilitation > Spinal Cord Injury

Posttraumatic Syringomyelia

Author: Lance Goetz, MD, Staff Physician, Spinal Cord Injury Center, Dallas Veterans Affairs Medical Center; Associate Professor of Physical Medicine and Rehabilitation, University of Texas Southwestern Medical Center at Dallas
Coauthor(s): Michael Priebe, MD, Associate Professor, Department of Physical Medicine and Rehabilitation, Mayo Clinic of Rochester, Minnesota
Contributor Information and Disclosures

Updated: Oct 22, 2009

Introduction

Background

First described by Bastian in 1867, posttraumatic syringomyelia (PTS) refers to the development and progression of a cyst filled with cerebrospinal fluid (CSF) within the spinal cord. PTS is a relatively infrequent, but potentially devastating, complication following traumatic spinal cord injury (SCI). PTS is characterized clinically by the often insidious progression of pain and loss of sensorimotor function that may manifest many years after traumatic SCI. If left untreated, PTS can result in loss of function, chronic pain, respiratory failure, or death. (See images below and Images 1-2.)

This illustration shows a T1-weighted, cervical m...

This illustration shows a T1-weighted, cervical magnetic resonance imaging (MRI) scan of multiple syrinx cavities (arrows). Note the lowest thin cavity extending into the thoracic spinal cord.

This illustration shows a T1-weighted, cervical m...

This illustration shows a T1-weighted, cervical magnetic resonance imaging (MRI) scan of multiple syrinx cavities (arrows). Note the lowest thin cavity extending into the thoracic spinal cord.


This T2-weighted magnetic resonance imaging (MRI)...

This T2-weighted magnetic resonance imaging (MRI) scan (same patient as above) delineates the syrinx cavity. Note the spinal cord edema extending rostrally from the upper limit of the cavity.

This T2-weighted magnetic resonance imaging (MRI)...

This T2-weighted magnetic resonance imaging (MRI) scan (same patient as above) delineates the syrinx cavity. Note the spinal cord edema extending rostrally from the upper limit of the cavity.


Pathophysiology

The pathophysiology is not understood fully (see Causes). Formation of a cavity within the spinal cord is common after traumatic SCI. Factors related to initial cavity formation include liquefaction of intraparenchymal hematoma, ischemia due to tethering, arterial or venous obstruction, release of intracellular lysosomal enzymes and excitatory amino acids, and mechanical damage from cord compression. Cavity formation alone is not considered PTS.

In PTS, cavity formation is followed by enlargement and extension of the cystic cavity. Rostral or caudal cyst extension may occur due to turbulent CSF flow or a "one-way valve" phenomenon that allows CSF into, but not out of, the cyst cavity. Tethering of the spinal cord, which results in impaired CSF circulation around the traumatized segment of spinal cord, occurs as a sequela of bleeding-induced arachnoiditis, scarring, spinal canal stenosis, or kyphotic deformity.

The "slosh-and-suck" theory proposes that increased epidural venous flow occurring during activities (eg, coughing, sneezing) that produce effects like the Valsalva maneuver results in increased pressure around the spinal cord, which cannot be dissipated because of disruptions in CSF flow. This pressure may force CSF into the cyst, resulting in expansion and extension.

A model developed by Carpenter et al suggests that a cough or sneeze can produce a pressure wave that would, in turn, give rise to a shocklike elastic jump.1,2 According to the model, the elastic jump could create a transient high-pressure region in the spinal cord, resulting in fluid accumulation. However, in an analysis of the model, Elliott et al maintained that the effect of an elastic jump would probably be too weak for fluid accumulation to result and that "the polarity of the pressure differential set up by cough-type impulses opposes the tenets of the elastic-jump hypothesis."3 The authors conclude that, based on their analysis, cough-based pressure impulses cannot cause syringomyelia.

Frequency

United States

Approximately 3-4% of persons with traumatic SCI develop clinically symptomatic PTS. A larger percentage of persons have clinically silent syrinx cavities diagnosed by imaging techniques.

Mortality/Morbidity

Morbidity is associated with weakness, loss of function, and chronic pain. Mortality can occur from involvement of brainstem respiratory centers or surgical complications.

Race

No racial differences are known for development of PTS.

Sex

The incidence of PTS is higher in men due to the increased frequency of SCI in males; however, there is no association of manifestations of the condition with the patient's sex.

Age

Development of PTS can occur at any age, and may begin at any time after traumatic SCI. Cases are reported as early as 1 month or as late as 45 years following injury.

Clinical

History

  • Pain is the most commonly reported symptom. Pain may be localized or diffuse and commonly is reported as a dull ache or a burning or stabbing sensation.
  • Other symptoms include increased weakness, numbness, increased spasticity, and hyperhidrosis (increased sweating).
  • Symptoms often are aggravated by postural change or the effects of the Valsalva maneuver.
  • Decreased reflex micturition, progressive orthostasis, autonomic dysreflexia, and relatively painless joint deformity or swelling (Charcot joint) also may be reported.

Physical

  • Spasticity often is increased compared to findings noted in prior examinations. Deep tendon reflex changes (either increased or decreased) may be noted compared with findings from prior examinations.
  • Ascending sensory level and sensory dissociation (selective loss of pain and temperature sensation) are very sensitive indicators for detecting progressive PTS. Numbness may involve the face if the syrinx has ascended into the brainstem. (See image below and Image 4.)
T2-weighted sagittal image of large, multiloculat...

T2-weighted sagittal image of large, multiloculated cervical syrinx extending into brainstem. Patient had preserved functional status.

T2-weighted sagittal image of large, multiloculat...

T2-weighted sagittal image of large, multiloculated cervical syrinx extending into brainstem. Patient had preserved functional status.

  • Progressive weakness and wasting can occur but may be a late finding.
  • Other signs may include a complete or partial Horner syndrome or other evidence of dysautonomia (eg, labile blood pressure, hyperhidrosis).
  • Signs may be unilateral because ascension of syrinxes often occurs unilaterally.

Causes

Traumatic SCI with tethering of the spinal cord to the dura results in impaired CSF circulation. Incomplete spinal canal decompression may predispose the person to tethering and CSF obstruction. These factors are thought to cause syrinx development.

Research supports the concept that chronic mechanical stress to the spinal cord increases the risk for development of syringomyelia. Spinal instrumentation without decompression is also associated with earlier onset of syringomyelia.

More on Posttraumatic Syringomyelia

Overview: Posttraumatic Syringomyelia
Differential Diagnoses & Workup: Posttraumatic Syringomyelia
Treatment & Medication: Posttraumatic Syringomyelia
Follow-up: Posttraumatic Syringomyelia
Multimedia: Posttraumatic Syringomyelia
References
Further Reading

References

  1. Berkouk K, Carpenter PW, Lucey AD. Pressure wave propagation in fluid-filled co-axial elastic tubes. Part 1: Basic theory. J Biomech Eng. Dec 2003;125(6):852-6. [Medline].

  2. Carpenter PW, Berkouk K, Lucey AD. Pressure wave propagation in fluid-filled co-axial elastic tubes. Part 2: Mechanisms for the pathogenesis of syringomyelia. J Biomech Eng. Dec 2003;125(6):857-63. [Medline].

  3. Elliott NS, Lockerby DA, Brodbelt AR. The pathogenesis of syringomyelia: a re-evaluation of the elastic-jump hypothesis. J Biomech Eng. Apr 2009;131(4):044503. [Medline].

  4. Sixt C, Riether F, Will BE, et al. Evaluation of quality of life parameters in patients who have syringomyelia. J Clin Neurosci. Oct 7 2009;[Medline].

  5. Lam S, Batzdorf U, Bergsneider M. Thecal shunt placement for treatment of obstructive primary syringomyelia. J Neurosurg Spine. Dec 2008;9(6):581-8. [Medline].

  6. Cacciola F, Capozza M, Perrini P, et al. Syringopleural shunt as a rescue procedure in patients with syringomyelia refractory to restoration of cerebrospinal fluid flow. Neurosurgery. Sep 2009;65(3):471-6; discussion 476. [Medline].

  7. Kunert P, Janowski M, Zakrzewska A, et al. Syringoperitoneal shunt in the treatment of syringomyelia. Neurol Neurochir Pol. May-Jun 2009;43(3):258-62. [Medline].

  8. Abel R, Gerner HJ, Smit C, Meiners T. Residual deformity of the spinal canal in patients with traumatic paraplegia and secondary changes of the spinal cord. Spinal Cord. Jan 1999;37(1):14-9. [Medline].

  9. Asano M, Fujiwara K, Yonenobu K, Hiroshima K. Post-traumatic syringomyelia. Spine. Jun 15 1996;21(12):1446-53. [Medline].

  10. Bains RS, Althausen PL, Gitlin GN, et al. The role of acute decompression and restoration of spinal alignment in the prevention of post-traumatic syringomyelia: case report and review of recent literature. Spine. Sep 1 2001;26(17):E399-402. [Medline].

  11. Batzdorf U, Klekamp J, Johnson JP. A critical appraisal of syrinx cavity shunting procedures. J Neurosurg. Sep 1998;89(3):382-8. [Medline].

  12. Biyani A, el Masry WS. Post-traumatic syringomyelia: a review of the literature. Paraplegia. Nov 1994;32(11):723-31. [Medline].

  13. Bonsanto MM, Metzner R, Aschoff A. 3D ultrasound navigation in syrinx surgery - a feasibility study. Acta Neurochirurgica. 2005;147(5):533-41.

  14. Carroll AM, Brackenridge P. Post-traumatic syringomyelia: a review of the cases presenting in a regional spinal injuries unit in the north east of England over a 5-year period. Spine. 2005;30(10):1206-10. [Medline].

  15. Edgar R, Quail P. Progressive post-traumatic cystic and non-cystic myelopathy. Br J Neurosurg. 1994;8(1):7-22. [Medline].

  16. el Masry WS, Biyani A. Incidence, management, and outcome of post-traumatic syringomyelia. In memory of Mr Bernard Williams. J Neurol Neurosurg Psychiatry. Feb 1996;60(2):141-6. [Medline].

  17. Falci S, Holtz A, Akesson E, et al. Obliteration of a posttraumatic spinal cord cyst with solid human embryonic spinal cord grafts: first clinical attempt. J Neurotrauma. Nov 1997;14(11):875-84.

  18. Falci SP, Lammertse DP, Best L, et al. Surgical treatment of posttraumatic cystic and tethered spinal cords. J Spinal Cord Med. 1999;22(3):173-81. [Medline].

  19. Goldstein B, Hammond MC, Stiens SA, Little JW. Posttraumatic syringomyelia: profound neuronal loss, yet preserved function. Arch Phys Med Rehabil. Jan 1998;79(1):107-12. [Medline].

  20. Green BA, Lee TT, Madsen PW. Management of posttraumatic cystic myelopathy. Top Spinal Cord Inj Rehabil. 1997;2(4):36-46.

  21. Hida K, Iwasaki Y, Imamura H, Abe H. Posttraumatic syringomyelia: its characteristic magnetic resonance imaging findings and surgical management. Neurosurgery. Nov 1994;35(5):886-91; discussion 891. [Medline].

  22. Kenan S, Lewis MM, Main WK, et al. Neuropathic arthropathy of the shoulder mimicking soft tissue sarcoma. Orthopedics. Oct 1993;16(10):1133-6. [Medline].

  23. Laxton AW, Perrin RG. Cordectomy for the treatment of posttraumatic syringomyelia. Report of four cases and review of the literature. Journal of Neurosurgery Spine. 2006;4(2):174-8.

  24. Lee TT, Alameda GJ, Camilo E. Surgical treatment of post-traumatic myelopathy associated with syringomyelia. Spine. 2001;26(24 Suppl):S119-27.

  25. Little JW, Robinson LR. AAEM case report #24: electrodiagnosis in posttraumatic syringomyelia. Muscle Nerve. Jul 1992;15(7):755-60. [Medline].

  26. Little JW, Robinson LR, Goldstein B, et al. Electrophysiologic findings in post-traumatic syringomyelia: implications for clinical management. J Am Paraplegia Soc. Apr 1992;15(2):44-52. [Medline].

  27. Milhorat TH, Capocelli AL Jr, Anzil AP, et al. Pathological basis of spinal cord cavitation in syringomyelia: analysis of 105 autopsy cases. J Neurosurg. May 1995;82(5):802-12. [Medline].

  28. Milhorat TH, Capocelli AL Jr, Kotzen RM, et al. Intramedullary pressure in syringomyelia: clinical and pathophysiological correlates of syrinx distension. Neurosurgery. Nov 1997;41(5):1102-10. [Medline].

  29. Milhorat TH, Johnson WD, Miller JI, et al. Surgical treatment of syringomyelia based on magnetic resonance imaging criteria. Neurosurgery. Aug 1992;31(2):231-44; discussion 244-5. [Medline].

  30. Milhorat TH, Kotzen RM, Mu HT, et al. Dysesthetic pain in patients with syringomyelia. Neurosurgery. May 1996;38(5):940-6; discussion 946-7. [Medline].

  31. Nielsen OA, Biering-Sorensen F, Botel U, et al. Post-traumatic syringomyelia. Spinal Cord. Oct 1999;37(10):680-4. [Medline].

  32. Nogues MA. Spontaneous electromyographic activity in spinal cord lesions. [Review]. Muscle & Nerve. 2002;Suppl. 11:s77-82.

  33. Perrouin-Verbe B, Lenne-Aurier K, Robert R, et al. Post-traumatic syringomyelia and post-traumatic spinal canal stenosis: a direct relationship: review of 75 patients with a spinal cord injury. Spinal Cord. Feb 1998;36(2):137-43. [Medline].

  34. Piepmeier JM, Jenkins NR. Late neurological changes following traumatic spinal cord injury. J Neurosurg. Sep 1988;69(3):399-402. [Medline].

  35. Rittenberg JD, Burns SP, Little JW. Worsening myelopathy masked by peripheral nerve disorders. J Spinal Cord Med. 2004;27(1):72-7.

  36. Rossier AB, Foo D, Shillito J, Dyro FM. Posttraumatic cervical syringomyelia. Incidence, clinical presentation, electrophysiological studies, syrinx protein and results of conservative and operative treatment. Brain. Jun 1985;108 ( Pt 2):439-61. [Medline].

  37. Schurch B, Wichmann W, Rossier AB. Post-traumatic syringomyelia (cystic myelopathy): a prospective study of 449 patients with spinal cord injury. J Neurol Neurosurg Psychiatry. Jan 1996;60(1):61-7. [Medline].

  38. Schwartz ED, Falcone SF, Quencer RM, Green BA. Posttraumatic syringomyelia: pathogenesis, imaging, and treatment. AJR Am J Roentgenol. Aug 1999;173(2):487-92. [Medline].

  39. Sgouros S, Williams B. A critical appraisal of drainage in syringomyelia. J Neurosurg. Jan 1995;82(1):1-10. [Medline].

  40. Silber JS, Vaccaro AR, Green B. Summary statement: chronic long-term sequelae after spinal cord injury: post-traumatic spinal deformity and post-traumatic myelopathy associated with syringomyelia.[comment]. Spine. 2001;26(24 Suppl):S128.

  41. Umbach I, Heilporn A. Review article: post-spinal cord injury syringomyelia. Paraplegia. May 1991;29(4):219-21. [Medline].

  42. Vannemreddy SS, Rowed DW, Bharatwal N. Posttraumatic syringomyelia: predisposing factors. Br J Neurosurgery. 2002;16(3):276-83.

  43. Williams B. Post-traumatic syringomyelia, an update. Paraplegia. Jun 1990;28(5):296-313. [Medline].

Keywords

posttraumatic syringomyelia, syringomyelia, SCI, spinal cord injury, syrinx, spinal cyst, spinal cysts, spinal cord cyst, syringomyelia symptoms, syringomyelia surgery, posttraumatic spinal cord injury

Contributor Information and Disclosures

Author

Lance Goetz, MD, Staff Physician, Spinal Cord Injury Center, Dallas Veterans Affairs Medical Center; Associate Professor of Physical Medicine and Rehabilitation, University of Texas Southwestern Medical Center at Dallas
Lance Goetz, MD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, American Paraplegia Society, American Spinal Injury Association, Association of Academic Physiatrists, and International Spinal Cord Society
Disclosure: Nothing to disclose.

Coauthor(s)

Michael Priebe, MD, Associate Professor, Department of Physical Medicine and Rehabilitation, Mayo Clinic of Rochester, Minnesota
Michael Priebe, MD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, American Congress of Rehabilitation Medicine, American Paraplegia Society, American Spinal Injury Association, International Society of Physical and Rehabilitation Medicine, and International Spinal Cord Society
Disclosure: Nothing to disclose.

Medical Editor

Robert L Sheridan, MD, Assistant Chief of Staff, Chief of Burn Surgery, Shriners Burns Hospital; Associate Professor of Surgery, Department of Surgery, Division of Trauma and Burns, Massachusetts General Hospital and Harvard Medical School
Robert L Sheridan, MD is a member of the following medical societies: American Academy of Pediatrics, American Association for the Surgery of Trauma, American Burn Association, and American College of Surgeons
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Patrick M Foye, MD, FAAPMR, FAAEM, Associate Professor of Physical Medicine and Rehabilitation, Co-Director of Musculoskeletal Fellowship, Co-Director of Back Pain Clinic, Director of Coccyx Pain Service (Tailbone Pain Service: www.TailboneDoctor.com), University of Medicine and Dentistry of New Jersey, New Jersey Medical School
Patrick M Foye, MD, FAAPMR, FAAEM is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, American Association of Neuromuscular and Electrodiagnostic Medicine, Association of Academic Physiatrists, and International Spine Intervention Society
Disclosure: Nothing to disclose.

CME Editor

Kelly L Allen, MD, Regional Medical Director, IMX-Medical Management Services
Disclosure: Nothing to disclose.

Chief Editor

Denise I Campagnolo, MD, MS, Director of Multiple Sclerosis Clinical Research and Staff Physiatrist, Barrow Neurology Clinics, St Joseph's Hospital and Medical Center; Investigator for Barrow Neurology Clinics; Director, NARCOMS Project for Consortium of MS Centers
Denise I Campagnolo, MD, MS is a member of the following medical societies: Alpha Omega Alpha, American Association of Neuromuscular and Electrodiagnostic Medicine, American Paraplegia Society, Association of Academic Physiatrists, and Consortium of Multiple Sclerosis Centers
Disclosure: Teva Neuroscience Honoraria Speaking and teaching; Serono-Pfizer Honoraria Speaking and teaching; Genzyme Corporation Grant/research funds investigator; Biogen Idec Grant/research funds investigator; Genentech, Inc Grant/research funds investigator; Eli Lilly & Company Grant/research funds Novaritis; Novaritis  Novaritis; MSDx LLC Grant/research funds investigator; BioMS Technology Corp Grant/research funds investigator; Avanir Pharmaceuticals Grant/research funds investigator

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.